Skip to main content

Formulation, Bioavailability, and Manufacturing Process Enhancement: Novel Applications of Melt Extrusion in Enabling Product Development

  • Chapter
  • First Online:
Melt Extrusion

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 9))

Abstract

Melt extrusion is increasingly popular in pharmaceutical applications due to a host of benefits it confers. However, due to the technology’s relatively more recent introduction into pharmaceutical processing, challenges in the development of extrusion based formulations/processes as well as the strategies to resolve them may not be as widely understood as the benefits. This chapter illustrates strategies to resolve challenges in the development of extruder-based formulations/processes using case studies on poorly soluble drugs (a) that are thermosensitive, (b) that exhibit high, or (c) low melting points and glass transition temperatures. Additional case studies also illustrate strategies to enable (d) very high drug loads of up to 95 % for highly water-soluble drugs and (e) moisture-sensitive drugs. As these case studies represent a small part of the expanding universe of melt extrusion applications and a ready-to-use solutions that address the challenges become increasingly available, it is fair to expect that twin-screw extrusion will continue to emerge as a powerful technology solution to a number of pharmaceutical formulation/process challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bhattacharya S, Suryanarayanan R (2009) Local mobility in amorphous pharmaceuticals—characterization and implications on stability. J Pharm Sci 98(9):2935–2953

    Article  PubMed  CAS  Google Scholar 

  • Bika D, Tardos GI, Panmai S, Farber L, Michaels J (2005) Strength and morphology of solid bridges in dry granules of pharmaceutical powders. Adv Powder Technol 150:104–116

    Article  CAS  Google Scholar 

  • Billings SW, Bronlund JE, Paterson AHJ (2006) Effects of capillary condensation on the caking of bulk sucrose. J Food Process Eng 77:887–895

    Article  CAS  Google Scholar 

  • Bosselmann S, Williams RO (2012) Route-specific challenges in the delivery of poorly water-soluble drugs. In: Williams RO, Watts AB, Miller DA (eds) Formulating poorly water soluble drugs, AAPS advances in the pharmaceutical sciences series. Springer, New York

    Google Scholar 

  • Bramah J. (1802) UK Patent No. 2652. 1802. Per Wikipedia article on Joseph Bramah. http://en.wikipedia.org/wiki/Joseph_Bramah. Accessed 18 July 2012

  • Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 54(2):107–117

    Article  PubMed  CAS  Google Scholar 

  • Crowley MM, Zhang F, Koleng JJ, McGinity JW (2002) Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. BioMaterials 23(21):4241–4248

    Article  PubMed  CAS  Google Scholar 

  • De Brabander C, Vervaet C, Remon JP (2003) Development and evaluation of sustained release mini matrices prepared via hot melt extrusion. J Control Release 89:235–247

    Article  PubMed  CAS  Google Scholar 

  • Desai D, Li D (2003) Evaluation of anti-caking agents for metformin hydrochloride and metformin-glipizide granulations. http://www.aapsj.org/abstracts/Am_2003/AAPS2003-002575.PDF. Accessed 26 Mar 2013

  • Dinunzio JC, Brough C, Hughey JR, Miller DA, Williams RO 3rd, McGinity JW (2010) Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing. Eur J Pharm Biopharm 74(2):340–351

    Article  PubMed  CAS  Google Scholar 

  • Evrard B, Amighi K, Beten D, Delattre L, Moes AJ (1999) Influence of melting and rheological properties of fatty binders on the melt granulation process in a high shear mixer. Drug Dev Ind Pharm 25:1177–1184

    Article  PubMed  CAS  Google Scholar 

  • Gao J, Walsh GC, Bigio D, Briber RM, Wetzel MD (2000) Mean residence time analysis for twin screw extruders. Polym Eng Sci 40:227–237

    Article  CAS  Google Scholar 

  • Ghosh I, Vippagunta R, Li S, Vippagunta S (2012) Key considerations for optimization of formulation and melt-extrusion process parameters for developing thermosensitive compound. Pharm Dev Technol 17(4):502–510

    Article  PubMed  CAS  Google Scholar 

  • Hancock BC, Zografi G (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86(1):1–12

    Article  PubMed  CAS  Google Scholar 

  • Hancock BC, Parks M (2000) What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17(4):397–404

    Article  PubMed  CAS  Google Scholar 

  • Hancock BC, Shamblin SL, Zografi G (1995) Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures. Pharm Res 12:799–806

    Article  PubMed  CAS  Google Scholar 

  • Huang YB, Tsai YH, Yang WC, Cang JS, Wu PC, Takayama K (2004) Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm 58:607–614

    Article  PubMed  CAS  Google Scholar 

  • Hughey JR, Keen JM, Brough C, Saeger S, McGinity JW (2011) Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® dispersing. Int Pharmaceutics 419(1–2):222–230

    Article  CAS  Google Scholar 

  • Killeen MJ (1993) The process of spray drying and spray congealing. Pharm Eng 13:56–64

    Google Scholar 

  • Kanno H (1981) A simple derivation of the empirical rule TG/TM = 2/3. J Non-Cryst Solids 44:409–413

    Article  CAS  Google Scholar 

  • Lakshman JP (2005) Process for making pharmaceutical compositions with a transient plasticizer. Patent number WO2007106182A3

    Google Scholar 

  • Lakshman JP, Cao Y, Kowalski j, Serajuddin ATM (2008) Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm 5(6):994–1002

    Article  PubMed  CAS  Google Scholar 

  • Lakshman JP, Kowalski J, Vasanthavada M, Tong W, Joshi Y, Serajuddin ATM (2011) Application of melt granulation technology to enhance tabletting properties of poorly compactible high-dose drugs. J Pharm Sci 100(4):1553–1565

    Article  PubMed  CAS  Google Scholar 

  • Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47–60

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Zhang F, McGinity JW (2001) Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm 52:181–190

    Article  PubMed  CAS  Google Scholar 

  • Liu H, Wang P, Zhang X, Shen F, Gogos CG (2010) Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit® E PO solid dispersions. Int J Pharm 383:161–169

    Article  PubMed  CAS  Google Scholar 

  • Newman A, Knipp G, Zografi G (2012) Assessing the performance of amorphous solid dispersions. J Pharm Sci 101(4):1355–1377

    Article  PubMed  CAS  Google Scholar 

  • Oksanen CA, Zografi G (1990) The relationship between the glass transition temperature and water vapor absorption by poly (vinylpyrrolidone). Pharm Res 7(6):654–657

    Article  PubMed  CAS  Google Scholar 

  • Paudel A, Worku ZA, Meeus J, Guns S, Van den Mooter G (2012) Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 2012 Jul 20. [Epub ahead of print]

    Google Scholar 

  • Railkar AM, Schwartz JB (2000) Evaluation and comparison of a moist granulation technique to conventional methods. Drug Dev Ind Pharm 26(8):885–889

    Article  PubMed  CAS  Google Scholar 

  • Royce A, Suryawanshi J, Shah U, Vishnupad K (1996) Alternative granulation technique: melt granulation. Drug Dev Ind Pharm 22:917–924

    Article  CAS  Google Scholar 

  • Schneider AK (1972) Polylactide sutures. US Patent 3, 636, 956. 1972

    Google Scholar 

  • Serajuddin A (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88(10):1058–1066

    Article  PubMed  CAS  Google Scholar 

  • Sung KC, Nixon PR, Skoug JW, Ju TR, Gao P, Topp EM, Patel MV (1996) Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int J Pharm 142:53–60

    Article  CAS  Google Scholar 

  • Sun CC, Hou H, Gao P, Ma C, Medina C, Alvarez FJ (2009) Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. J Pharm Sci 98(1):239–247

    Article  PubMed  CAS  Google Scholar 

  • Tsuk AG, Martin FH (1976) Dosage form. US Patent 3(972):995

    Google Scholar 

  • Van Melkebekea B, Vermeulena B, Vervaet CRemonJP (2006) Melt granulation using a twin-screw extruder: a case study. Int J Pharm 326:1–2

    Article  Google Scholar 

  • Vasanthavada M, Wang Y, Haefele T, Lakshman JP, Mone M, Tong W, Joshi YM, Serajuddin ATM (2011) Application of melt granulation technology using twin-screw extruder in development of high-dose modified-release tablet formulation. J Pharm Sci 100(5):1923–1934

    Article  PubMed  CAS  Google Scholar 

  • Windbergs M, Strachan CJ, Kleinebudde P (2009) Understanding the solid-state behavior of triglyceride solid lipid extrudates and its influence on dissolution. Eur J Pharm Biopharm 71:80–87

    Article  PubMed  CAS  Google Scholar 

  • Young CR, Dietzsch C, Cerea M, Farrell T, Fegely KA, Rajabi-Siahboomi A, McGinity J (2005) Physicochemical characterization and mechanism of release of theophylline from melt-extruded dosage forms based on methacrylic acid copolymer. Int J Pharm 301:112–120

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author wishes to acknowledge several colleagues from Novartis for their experimental support, many discussions, and insights: Al Hollywood, Arun Patel, Jim Kowalski, Madhav Vasanthavada, Vivian Georgousis, Yu Cao, Jennifer Snyder, Marilyn Alvine, Bal Reddy, and Raju Vegesna; and Mike Motto, Colleen Ruegger, Steve Krill, Tony Tong, Ann Comfort, Alan Royce, Abu Serajuddin, and Yatindra Joshi for their support and encouragement.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jay P. Lakshman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Lakshman, J. (2013). Formulation, Bioavailability, and Manufacturing Process Enhancement: Novel Applications of Melt Extrusion in Enabling Product Development. In: Repka, M., Langley, N., DiNunzio, J. (eds) Melt Extrusion. AAPS Advances in the Pharmaceutical Sciences Series, vol 9. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8432-5_14

Download citation

Publish with us

Policies and ethics